CRA’s Lev Gerlovin and co-authors Walter Colasante and Pascale Diesel published a series of three articles in Cell & Gene on emerging gene and cell therapies and their impact on the market.
Read the full series below:
TrumpRx: Enabling direct-to-patient care?
As of December 11, 2025, a variety of manufacturers have reached agreements or stated their intent to offer discounted prices for some of their medications...